BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 20 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | -56.4% | 22,590 | -32.1% | 0.00% | – |
| Q2 2022 | $39,000 | -50.6% | 33,281 | -30.1% | 0.00% | – |
| Q1 2022 | $79,000 | -23.3% | 47,632 | +9.2% | 0.00% | – |
| Q4 2021 | $103,000 | +3.0% | 43,623 | -4.2% | 0.00% | – |
| Q3 2021 | $100,000 | -32.4% | 45,544 | -11.7% | 0.00% | – |
| Q2 2021 | $148,000 | -5.7% | 51,592 | +24.3% | 0.00% | – |
| Q1 2021 | $157,000 | -8.2% | 41,521 | -31.7% | 0.00% | – |
| Q4 2020 | $171,000 | -91.0% | 60,803 | +24.9% | 0.00% | – |
| Q3 2020 | $1,902,000 | +1923.4% | 48,666 | +1085.5% | 0.00% | – |
| Q2 2020 | $94,000 | +4600.0% | 4,105 | +1791.7% | 0.00% | – |
| Q1 2020 | $2,000 | -66.7% | 217 | -67.5% | 0.00% | – |
| Q4 2019 | $6,000 | +50.0% | 668 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | 0.0% | 668 | -0.4% | 0.00% | – |
| Q2 2019 | $4,000 | +33.3% | 671 | +28.5% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 522 | +11.1% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 470 | +2.2% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 460 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | +50.0% | 460 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -75.0% | 460 | -71.0% | 0.00% | – |
| Q4 2017 | $8,000 | +166.7% | 1,585 | +211.4% | 0.00% | – |
| Q3 2017 | $3,000 | +50.0% | 509 | +158.4% | 0.00% | – |
| Q2 2017 | $2,000 | – | 197 | +6466.7% | 0.00% | – |
| Q1 2016 | $0 | – | 3 | +50.0% | 0.00% | – |
| Q4 2015 | $0 | – | 2 | -33.3% | 0.00% | – |
| Q2 2015 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|